Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Cholecystitis01:20

Cholecystitis

Cholecystitis is inflammation of the gallbladder, most commonly caused by obstruction of the cystic duct. This blockage prevents bile from draining, leading to gallbladder distension, inflammation, and potentially serious complications. This condition may present acutely or chronically and can happen with or without gallstones.EtiologyAbout 95% of cholecystitis cases are calculous, caused by gallstones blocking the cystic duct, leading to bile accumulation and inflammation of the gallbladder...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gene-body DNA methylation of ONECUT2 predicts its expression and prostate cancer aggressiveness in needle biopsies.

Biomarker research·2026
Same author

DNA Binding by BosR Controls RpoS-Dependent and -Independent Gene Expression in Borrelia burgdorferi.

Molecular microbiology·2025
Same author

ONECUT2: a validated drug target and lineage plasticity driver in prostate cancer and other malignancies.

Endocrine-related cancer·2025
Same author

Comparison of QuPath and HALO Platforms for Analysis of the Tumor Microenvironment in Prostate Cancer.

Laboratory investigation; a journal of technical methods and pathology·2025
Same author

ONECUT2 reprograms neuroendocrine fate and is an actionable therapeutic target in small cell lung cancer.

Molecular medicine (Cambridge, Mass.)·2025
Same author

Extracellular vesicle heterogeneity through the lens of multiomics.

Cell reports. Medicine·2025
Same journal

Direct Reciprocal Repression between Goosecoid and Ventx1.1 Modulates Dorsoventral Patterning in Xenopus.

Differentiation; research in biological diversity·2026
Same journal

Validated CRISPR/Cas9 guide RNAs targeting neurodevelopmental genes in the tunicate Ciona robusta.

Differentiation; research in biological diversity·2026
Same journal

Corrigendum to "Histone H2A deubiquitinase BAP1 is required for human neuronal progenitor cell formation" [Differentiation 149 (2026) 100957].

Differentiation; research in biological diversity·2026
Same journal

Human heel fat pad development before birth.

Differentiation; research in biological diversity·2026
Same journal

Bridging cells: Potential crosstalk between the peripheral and central olfactory sensory system.

Differentiation; research in biological diversity·2026
Same journal

Osteoclast-derived DEL1 promotes pathological bone formation in ankylosing spondylitis by regulating RUNX2 expression in osteoblasts.

Differentiation; research in biological diversity·2026
See all related articles

Related Experiment Video

Updated: May 30, 2026

Ultrasonography of the Adult Male Urinary Tract for Urinary Functional Testing
05:25

Ultrasonography of the Adult Male Urinary Tract for Urinary Functional Testing

Published on: August 14, 2019

Cholesterol and benign prostate disease.

Michael R Freeman1, Keith R Solomon

  • 1The Urological Diseases Research Center, Children's Hospital Boston, Enders Research Laboratories, 300 Longwood Ave., Boston, MA 02115, USA. michael.freeman@childrens.harvard.edu

Differentiation; Research in Biological Diversity
|August 25, 2011
PubMed
Summary
This summary is machine-generated.

Cholesterol metabolism impacts benign prostate diseases like benign prostatic hyperplasia (BPH). Targeting cholesterol may offer new treatments for prostate conditions and reduce cancer risk.

More Related Videos

Enrichment of Mammalian Tissues and Xenopus Oocytes with Cholesterol
10:12

Enrichment of Mammalian Tissues and Xenopus Oocytes with Cholesterol

Published on: March 25, 2020

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

Related Experiment Videos

Last Updated: May 30, 2026

Ultrasonography of the Adult Male Urinary Tract for Urinary Functional Testing
05:25

Ultrasonography of the Adult Male Urinary Tract for Urinary Functional Testing

Published on: August 14, 2019

Enrichment of Mammalian Tissues and Xenopus Oocytes with Cholesterol
10:12

Enrichment of Mammalian Tissues and Xenopus Oocytes with Cholesterol

Published on: March 25, 2020

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

Area of Science:

  • Urology
  • Metabolic Research
  • Oncology

Background:

  • Benign prostatic diseases, including benign prostatic hyperplasia (BPH) and chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS), have unclear origins.
  • These conditions significantly reduce patient quality of life, with uncertain links to prostate cancer.
  • Limited epidemiological data exists for BPH and CP/CPPS, but associations with cardiovascular disease (CVD) are noted.

Purpose of the Study:

  • To review evidence linking cholesterol metabolism to benign prostate disease incidence.
  • To explore potential therapeutic strategies targeting cholesterol metabolism for prostate conditions.
  • To investigate the role of cholesterol in prostate cancer development and progression.

Main Methods:

  • Review of existing epidemiological data on BPH, CP/CPPS, and cardiovascular disease.
  • Analysis of studies on cholesterol metabolism in prostate tissues.
  • Examination of findings from animal models and clinical trials on cholesterol-lowering agents.

Main Results:

  • Hypercholesterolemia is a risk factor for BPH, mirroring its role in CVD.
  • Agents inhibiting cholesterol absorption, like polyene macrolides, show potential in reducing prostate size and improving lower urinary tract symptoms (LUTS).
  • Cholesterol-lowering drugs are associated with reduced risk of aggressive prostate cancer, as cancer cell pathways are cholesterol-sensitive.

Conclusions:

  • Cholesterol metabolism is implicated in the development of benign prostate diseases.
  • Targeting cholesterol metabolism presents a promising therapeutic avenue for BPH and related conditions.
  • Further research into cholesterol's role may yield novel strategies for prostate cancer prevention and treatment.